Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.
Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.
According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.
It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.


Three killed in attacks on two Saudi airports
Russia hits Ukraine with drones and missiles, killing at least eight
Kagan and Soai win 2026 Nobel chemistry prize for single molecular mirror creation
Ten injured in knife attack at Polish school
Israelis mark three years since Hamas attack that set off Gaza assault
